|
|
Previous Article | Table of Contents | Next Article 
Expression of murine CD38 defines a population of long-term reconstituting
hematopoietic stem cells
TD Randall, FE Lund, MC Howard and IL Weissman
Department of Pathology, Stanford Medical School, CA 94305, USA.
Using a monoclonal antibody to murine CD38, we showed that a population of
adult bone marrow cells that expressed the markers Sca-1 and c-kit but
lacked the lineage markers Mac-1, GR-1, B220, IgM, CD3, CD4, CD8 and CD5
could be subdivided by the expression of CD38. We showed that CD38high
c-kit+ Sca-1+, linlow/-cells sorted from adult bone marrow cultured with
interleukin-3 (IL-3), IL-6, and kit-L produced much larger colonies in
liquid culture at a greater frequency than their CD38low/- counterparts. In
addition, we found that CD36low/ - cells contained most of the day-12
colony-forming units-spleen (CFU-S) but were not long-term reconstituting
cells, whereas the population that expressed higher levels of CD38
contained few, but significant, day-12 CFU-S and virtually all the
long-term reconstituting stem cells. Interestingly, the CD38high Sca-1+
c-kit+ linlow/- cells isolated from day-E14.5 fetal liver were also found
to be long-term reconstituting stem cells. This is in striking contrast to
human hematopoietic progenitors in which the most primitive hematopoietic
cells from fetal tissues lack the expression of CD38. Furthermore, because
antibodies to CD38 could functionally replace antibodies to Thy-1.1 in a
stem cell purification procedure, the use of anti-CD38 may be more
generally applicable to the purification of hematopoietic stem cells from
mouse strains that do not express the Thy-1.1 allele.
Volume 87,
Issue 10,
pp. 4057-4067,
05/15/1996
Copyright © 1996 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Kikushige, G. Yoshimoto, T. Miyamoto, T. Iino, Y. Mori, H. Iwasaki, H. Niiro, K. Takenaka, K. Nagafuji, M. Harada, et al.
Human Flt3 Is Expressed at the Hematopoietic Stem Cell and the Granulocyte/Macrophage Progenitor Stages to Maintain Cell Survival
J. Immunol.,
June 1, 2008;
180(11):
7358 - 7367.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Spooncer, N. Brouard, S. K. Nilsson, B. Williams, M. C. Liu, R. D. Unwin, D. Blinco, E. Jaworska, P. J. Simmons, and A. D. Whetton
Developmental Fate Determination and Marker Discovery in Hematopoietic Stem Cell Biology Using Proteomic Fingerprinting
Mol. Cell. Proteomics,
March 1, 2008;
7(3):
573 - 581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. K. Mullarky, F. M. Szaba, K. N. Berggren, L. W. Kummer, L. B. Wilhelm, M. A. Parent, L. L. Johnson, and S. T. Smiley
Tumor Necrosis Factor Alpha and Gamma Interferon, but Not Hemorrhage or Pathogen Burden, Dictate Levels of Protective Fibrin Deposition during Infection
Infect. Immun.,
February 1, 2006;
74(2):
1181 - 1188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. F. Beilhack, R. R. Landa, M. A. Masek, and J. A. Shizuru
Prevention of Type 1 Diabetes with Major Histocompatibility Complex-Compatible and Nonmarrow Ablative Hematopoietic Stem Cell Transplants
Diabetes,
June 1, 2005;
54(6):
1770 - 1779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Zhong, Y. Zhao, S. Sutton, A. Su, Y. Zhan, L. Zhu, C. Yan, T. Gallaher, P. B. Johnston, W. F. Anderson, et al.
Gene expression profile of murine long-term reconstituting vs. short-term reconstituting hematopoietic stem cells
PNAS,
February 15, 2005;
102(7):
2448 - 2453.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Sitnicka, N. Buza-Vidas, S. Larsson, J. M. Nygren, K. Liuba, and S. E. W. Jacobsen
Human CD34+ hematopoietic stem cells capable of multilineage engrafting NOD/SCID mice express flt3: distinct flt3 and c-kit expression and response patterns on mouse and candidate human hematopoietic stem cells
Blood,
August 1, 2003;
102(3):
881 - 886.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Dybedal, L. Yang, D. Bryder, I. Aastrand-Grundstrom, K. Leandersson, and S. E. W. Jacobsen
Human reconstituting hematopoietic stem cells up-regulate Fas expression upon active cell cycling but remain resistant to Fas-induced suppression
Blood,
July 1, 2003;
102(1):
118 - 126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. F. Beilhack, Y. C. Scheffold, I. L. Weissman, C. Taylor, L. Jerabek, M. J. Burge, M. A. Masek, and J. A. Shizuru
Purified Allogeneic Hematopoietic Stem Cell Transplantation Blocks Diabetes Pathogenesis in NOD Mice
Diabetes,
January 1, 2003;
52(1):
59 - 68.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. DiMartino, L. Selleri, D. Traver, M. T. Firpo, J. Rhee, R. Warnke, S. O'Gorman, I. L. Weissman, and M. L. Cleary
The Hox cofactor and proto-oncogene Pbx1 is required for maintenance of definitive hematopoiesis in the fetal liver
Blood,
August 1, 2001;
98(3):
618 - 626.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Tajima, T. Deguchi, J. H. Laver, H. Zeng, and M. Ogawa
Reciprocal expression of CD38 and CD34 by adult murine hematopoietic stem cells
Blood,
May 1, 2001;
97(9):
2618 - 2624.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Guilliano, A. E. Foxx-Orenstein, and D. A. Lebman
The Microenvironment of Human Peyer's Patches Inhibits the Increase in CD38 Expression Associated with the Germinal Center Reaction
J. Immunol.,
February 15, 2001;
166(4):
2179 - 2185.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-C. Hsu, H. Ema, M. Osawa, Y. Nakamura, T. Suda, and H. Nakauchi
Hematopoietic stem cells express Tie-2 receptor in the murine fetal liver
Blood,
December 1, 2000;
96(12):
3757 - 3762.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhao, Y. Lin, Y. Zhan, G. Yang, J. Louie, D. E. Harrison, and W. F. Anderson
Murine hematopoietic stem cell characterization and its regulation in BM transplantation
Blood,
November 1, 2000;
96(9):
3016 - 3022.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. G. Murante and T. A. Gasiewicz
Hemopoietic Progenitor Cells Are Sensitive Targets of 2,3,7,8-Tetrachlorodibenzo-p-dioxin in C57BL/6J Mice
Toxicol. Sci.,
April 1, 2000;
54(2):
374 - 383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Todisco, T. Suzuki, K. Srivannaboon, E. Coustan-Smith, S. C. Raimondi, F. G. Behm, A. Kitanaka, and D. Campana
CD38 ligation inhibits normal and leukemic myelopoiesis
Blood,
January 15, 2000;
95(2):
535 - 542.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Gush, K.-L. Fu, M. Grompe, and C. E. Walsh
Phenotypic correction of Fanconi anemia group C knockout mice
Blood,
January 15, 2000;
95(2):
700 - 704.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Storms, A. P. Trujillo, J. B. Springer, L. Shah, O. M. Colvin, S. M. Ludeman, and C. Smith
Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity
PNAS,
August 3, 1999;
96(16):
9118 - 9123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kitajima, M. Kojima, K. Nakajima, S. Kondo, T. Hara, A. Miyajima, and T. Takeuchi
Definitive But Not Primitive Hematopoiesis Is Impaired in jumonji Mutant Mice
Blood,
January 1, 1999;
93(1):
87 - 95.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Mebius, S. van Tuijl, I. L. Weissman, and T. D. Randall
Transfer of Primitive Stem/Progenitor Bone Marrow Cells from LT{alpha}-/- Donors to Wild-Type Hosts: Implications for the Generation of Architectural Events in Lymphoid B Cell Domains
J. Immunol.,
October 15, 1998;
161(8):
3836 - 3843.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Cockayne, T. Muchamuel, J. C. Grimaldi, H. Muller-Steffner, T. D. Randall, F. E. Lund, R. Murray, F. Schuber, and M. C. Howard
Mice Deficient for the Ecto-Nicotinamide Adenine Dinucleotide Glycohydrolase CD38 Exhibit Altered Humoral Immune Responses
Blood,
August 15, 1998;
92(4):
1324 - 1333.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Orlic, L. J. Girard, S. M. Anderson, L. C. Pyle, M. C. Yoder, H. E. Broxmeyer, and D. M. Bodine
Identification of Human and Mouse Hematopoietic Stem Cell Populations Expressing High Levels of mRNA Encoding Retrovirus Receptors
Blood,
May 1, 1998;
91(9):
3247 - 3254.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Cairo and J. E. Wagner
Placental and/or Umbilical Cord Blood: An Alternative Source of Hematopoietic Stem Cells for Transplantation
Blood,
December 15, 1997;
90(12):
4665 - 4678.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Yano, A. Iwama, H. Nishio, J. Suda, G. Takada, and T. Suda
Expression and Function of Murine Receptor Tyrosine Kinases, TIE and TEK, in Hematopoietic Stem Cells
Blood,
June 15, 1997;
89(12):
4317 - 4326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. D. Randall and I. L. Weissman
Phenotypic and Functional Changes Induced at the Clonal Level in Hematopoietic Stem Cells After 5-Fluorouracil Treatment
Blood,
May 15, 1997;
89(10):
3596 - 3606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Piacibello, F. Sanavio, L. Garetto, A. Severino, D. Bergandi, J. Ferrario, F. Fagioli, M. Berger, and M. Aglietta
Extensive Amplification and Self-Renewal of Human Primitive Hematopoietic Stem Cells From Cord Blood
Blood,
April 15, 1997;
89(8):
2644 - 2653.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|